Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 1
2002 2
2005 1
2006 1
2007 2
2008 1
2009 2
2010 2
2011 3
2012 4
2013 2
2014 3
2015 2
2016 3
2017 3
2018 7
2019 6
2020 1
2021 1
2022 2
2023 1
2024 6
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic Challenges for Pediatric Cancers.
Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA, Cairo MS, Roberts RD, Cripe TP, Cassady KA. Hutzen B, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2019 Aug 28;15:38-48. doi: 10.1016/j.omto.2019.08.005. eCollection 2019 Dec 20. Mol Ther Oncolytics. 2019. PMID: 31650024 Free PMC article. Review.
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.
Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS. Luo W, et al. Among authors: cassady ka. J Exp Clin Cancer Res. 2024 Jul 11;43(1):193. doi: 10.1186/s13046-024-03093-w. J Exp Clin Cancer Res. 2024. PMID: 38992659 Free PMC article.
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.
Kim Y, Saini U, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A, Mo X, Cripe TP, Markert J, Cassady KA, Dhital R. Kim Y, et al. Among authors: cassady ka. Front Immunol. 2024 Jun 4;15:1375413. doi: 10.3389/fimmu.2024.1375413. eCollection 2024. Front Immunol. 2024. PMID: 38895115 Free PMC article.
Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM, Friedman GK, Cassady KA, Markert JM. Foreman PM, et al. Among authors: cassady ka. Neurotherapeutics. 2017 Apr;14(2):333-344. doi: 10.1007/s13311-017-0516-0. Neurotherapeutics. 2017. PMID: 28265902 Free PMC article. Review.
The Antiviral Apparatus: STING and Oncolytic Virus Restriction.
Lee J, Ghonime MG, Wang R, Cassady KA. Lee J, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2019 Mar 20;13:7-13. doi: 10.1016/j.omto.2019.02.002. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 30989105 Free PMC article. Review.
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP. Paudel SN, et al. Among authors: cassady ka. Front Immunol. 2024 Jun 25;15:1384623. doi: 10.3389/fimmu.2024.1384623. eCollection 2024. Front Immunol. 2024. PMID: 39044819 Free PMC article.
61 results